TRIO PHARMA ApS: Financial statements 2023
CVR: 36499281
Source: annual report 2023, Danish Business Authority
01/05/2022 – 30/04/2023
TRIO PHARMA ApS (CVR 36499281) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -491,388 and a net result of DKK -889,359 compared with DKK 9,019,563 the year before. Equity in the 2023 report amounted to DKK -932,989. The company had 2 employees in the financial year.
- Gross Profit
- DKK -491,388
- Profit/Loss
- DKK -889,359
- Equity
- DKK -932,989
- Total Assets
- DKK 895,852
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -491 t. | -889 t. | -933 t. | 2 |
| 2022 | - | -423 t. | 9 mio. | -44 t. | 1 |
| 2021 | - | 361 t. | -152 t. | -1.3 mio. | 1 |
| 2020 | - | 85 t. | -361 t. | -1.1 mio. | 1 |
| 2019 | - | 134 t. | -232 t. | -750 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout TRIO PHARMA ApS
TRIO PHARMA ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christian Bo Ratje. The board consists of Michael John Ratje (chair), Christian Bo Ratje and Kirstine Laura Ratje-Johansen. The company is owned by STINE RATJE HOLDING ApS and CHRISTIAN RATJE HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK -411,555 and a net result of DKK -1,170,880 compared with DKK -489,664 the year before. Equity in the 2025 report amounted to DKK -2,593,533.